A B S T R A C T We have reported previously two siblings with gout and uric acid lithiasis associated with excessive purine production. In the erythrocytes of these patients, phosphoribosylpyrophosphate (PRPP) synthetase exhibited resistance to feedback-inhibition by normal cell constituents such as guanosine-5'-diphosphate (GDP) and adenosine-5'-diphosphate (ADP), resulting in superactivity of the mutant enzyme and consequently in increased PRPP content and availability for nucleotide synthesis. Erythrocyte PRPP content and availability were normal in the propositus' parents, his healthy brother and three sons, and they all had normal serum level and urinary excretion of uric acid, except for the mother who was hyperuricosuric. To further characterize this mutation we studied PRPP and purine metabolism in cultured fibroblasts of the affected family. PRPP synthetase in dialyzed lysates of fibroblasts from the propositus and his mother exhibited increased specific activity, more markedly at low inorganic phosphate concentration, and decreased sensitivity to inhibition by ADP and GDP. PRPP content and availability and the rate of de novo purine nucleotide synthesis were markedly increased in the fibroblasts of the propositus and to a lesser extent in the fibroblasts of his mother but were normal in the fibroblasts of the other family members investigated. The fibroblast stud-
in superactivity of the mutant enzyme and consequently in increased PRPP content and availability for nucleotide synthesis. Erythrocyte PRPP content and availability were normal in the propositus' parents, his healthy brother and three sons, and they all had normal serum level and urinary excretion of uric acid, except for the mother who was hyperuricosuric. To further characterize this mutation we studied PRPP and purine metabolism in cultured fibroblasts of the affected family. PRPP synthetase in dialyzed lysates of fibroblasts from the propositus and his mother exhibited increased specific activity, more markedly at low inorganic phosphate concentration, and decreased sensitivity to inhibition by ADP and GDP. PRPP content and availability and the rate of de novo purine nucleotide synthesis were markedly increased in the fibroblasts of the propositus and to a lesser extent in the fibroblasts of his mother but were normal in the fibroblasts of the other family members investigated. The fibroblast stud-INTRODUCTION Phosphoribosylpyrophosphate (PRPP)' synthetase catalyzes the formation of PRPP from ribose-5-phosphate and ATP. The enzyme is activated by inorganic phosphate (Pi) and inhibited by several cellular compounds such as adenosine-5'-diphosphate (ADP) and guanosine-5'-diphosphate (GDP) (1) . PRPP is a substrate for PRPP-amidotransferase, the first uniquely committed enzyme in the de novo synthesis of purine nucleotides, and is a potent regulator of this pathway. In human tissue the concentration of PRPP is limiting for the PRPP-amidotransferase reaction (2) . Furthermore, the velocity response of this reaction to PRPP concentration is sigmoidal in the presence of physiological inhibitors (3), a significant acceleration occurring in response to a relatively minor increase in the concentration of this substrate. Studies in vitro, utilizing cultured human skin fibroblasts, have demonstrated that methylene blue-induced increase of PRPP concentration accelerates purine synthesis de novo (4) .
In accordance with the above, it has been proposed that increased PRPP availability could be the common causal denominator in the accelerated de novo purine nucleotide synthesis associated with all known underlying enzymic abnormalities in man. Increased PRPP availability has been demonstrated in hypoxanthineguanine phosphoribosyltransferase (HGPRT) deficiency, complete in the Lesch-Nyhan syndrome, partial in some patients with metabolic gout (5) , and has been suggested in glucose-6-phosphatase deficiency (glycogen storage disease type I) (6) and superactivity of glutathione reductase (7) . Recently we reported a new familial enzyme abnormality associated with excessive purine production, gout, and uric lithiasis (8) (9) (10) . PRPP synthetase in the eythrocytes of the two affected siblings exhibited feedback-resistance to inhibition by several cellular compounds such as GDP and ADP, resulting in superactivity of the enzyme in the normal physiological milieu and consequently in increased PRPP content and availability for nucleotide synthesis. Study of other family members revealed normal PRPP availability in their erythrocytes, and serum level and urinary excretion of uric acid were found to be normal, except in the mother who was hyperuricosuric.
Two additional families with gout associated with increased PRPP synthetase activity have been described subsequently by Becker et al. (11, 12) . In these PRPP synthetase mutations the enzymes respond normally to the regulatory cofactors, and the structural alteration appears to involve the catalytic site of the enzyme only.
Cultured human fibroblasts possess the principal pathways of PRPP generation and, in contrast to the erythrocyte, also the complete pathways of purine metabolism, except for the last two steps of purine degradation catalyzed by the enzyme xanthine oxidase (13) . In the present study, cultured skin fibroblasts from the family affected with the mutant feedback-resistant PRPP synthetase were utilized to characterize the metabolic abnormalities caused by the mutation and to obtain data concerning the genetic pattern of this disorder.
METHODS
Subjccts. Propositus 0. G., at present 38-yr-old, has a history of recurrent bilateral uric acid lithiasis since the age of 14 and of severe gouty arthritis since the age of 20. Since the age of 29 he has received Allopurinol with excellent response. When temporarily off treatment his serum uric acid rose to 13.5 mg/100 ml, and his 24-h urinary uric acid excretion increased to 2,400 mg. The excessive rate of urine production in this patient was verified by the measurement of [15N] glycine incorporation into his urinary uric acid, amounting in 7 days to 3.32% of the administered dose, as compared to values of 0.12, 0.13, and 0.17% found in three normal subjects (14) . The similarly affected brother (H. G.) of the propositus was not available for the present study. There was no urolithiasis or gout in other family members, nor abnormality in serum level or urinary excretion of uric acid, except in the propositus' mother who is hyperuricosuric ( serum, folic acid (50 gg/ml), penicillin (100 U/ml), streptomycin (100 ,ug/ml), and mycostatin (25 fug/ml). The media were saturated with a 5% C02-95%o air environment, and the bottles were stoppered and incubated at 37°C until outgrowth was apparent. The cells were then subcultered and serially propagated until they become confluent. Cells used were from the 4th-15th passage and from confluent monolayers. In the study of purine synthesis de novo, in which the excretion of labeled purines bases into the medium was determined, nonconfluent cultures were employed. Cultures for each experiment were selected to be from a similar passage.
Assay of PRPP synth1etase. The fibroblasts were harvested by brief trypsinization, washed four times with saline, and suspended to the desired concentration in 4 mM potassium phosphate buffer. Fibroblast extracts were prepared by rapid freezing and thawing of the cells four times in dry ice and acetone. After centrifugation at 40,000 g for 25 min at 4°C, the supernate was dialyzed against 4,000 vol of 4 mM potassium phosphate buffer, pH 7.4, at 4°C for 5 h. PRPP synthetase was assayed essentially as described by Fox and Kelley (16) . The reaction mixture, a total volume of 200 Al, contained 30-150 ,g protein of the dialyzed cell lysate, 0.5 mM ATP, 0.5 mM ribose-5-phosphate, 5 mM magnesium chloride, and 2.5 mM mercaptoethanol in potassium phosphate buffer, pH 7.4, of the specified molarity. Incubation was carried for 15 min at 37' C. The PRPP was extracted by heat and determined as described (16) (17) . The nucleotide spots were scraped off and counted in a liquid scintillation counter (Packard Tri-Carb model 3380, Packard Instrument Co., Downers Grove, Ill.). The results are expressed in relation to the milligrams protein in dialyzed fibroblast lysate. The time of incubation and the amount of lysate protein in the experiments were selected to be within the linear range of the reaction velocity. The inhibitory effect of ADP and GDP on enzyme activity was studied by the addition of these nucleotides into the incubation mixture in the concentration specified. In these experi-1094 E. Zoref, A. de Vries, and 0. Sperling Al of distilled water and subjected to freezing and thawing four times. 100 Al of the cell lysate were transferred to a tube containing 100 Al of 10 mM EDTA in 10 mM TrisHCl, pH 7.4, heated at 85'C for 2 min, chilled, and centrifuged at 3,000 rpm for 10 min. PRPP, extracted in the supernate, was assayed as described by Fox and Kelley (16) . The reaction mixture, a total volume of 250 Al, contained 150 ul of the PRPP extract, 25 mM MgC12, 0.2 mM [8-"C] hypoxanthine (25 mCi/mmol), 100 Bug of partially purified human erythrocyte HGPRT (DEAE-cellulose extract treated for 2 min at 85'C to eliminate PRPP synthetase activity [18] [8-"C] hypoxanthine. The cell suspension were incubated in a shaking bath at 37'C for 15 min. After incubation the tubes were put immediately in ice, 10 ml of ice-cold saline was added, and the cells were washed five times with ice-cold saline, suspended in 0.5 ml of distilled water, and subjected to freezing and thawing four times. Protein and nucleic acids were precipitated by addition of 40 Al cold 42%o PCA, and the total "C-labeled nucleotides were separated and counted as described above. A saturating concentration of the labeled purine bases was used, the reaction exhibiting linearity for at least 30 min. The results are related to total cell protein.
Purine synthesis de novo. The rate of purine nucleotide synthesis de novo was studied in intact fibroblasts by measuring incorporation of ["C] formate into the total cellular nucleotide pool (soluble in cold 1 N PCA) and also into the total purines excreted into the incubation medium. The procedure was essentially that described by Martin and Owen (19) and Green and Martin (20) for cultured mutagenized hepatoma cells. For the study of incorporation of ['4C]formate into the total cellular nucleotide pool, 2.0-3.0 X 10' cells were suspended in fresh 10 ml growth medium containing 20 itCi sodium ["C]formate. The cell suspensions were gassed with 5% C02-95% air and incubated for 2 h in a shaking bath at 37'. After incubation, the flasks were placed in ice and immediately centrifuged at 40C, washed five times with ice-cold saline, and suspended in 0.5 ml of distilled water and subjected to freezing and thawing seven times. 0.5 ml 2 N PCA and 0.2 /Ci of [8- 3H]adenine were added, and the tubes were throughly mixed and put in ice for 1 h. After centrifugation the purine nucleotides in the supernate were hydrolyzed at 1000C for 1 h. The hydrolysate was adjusted with water to a volume of 1.5 ml and chilled and 0.7 mg adenine was added to each tube as carrier. The purine bases were then precipitated as a purine-silver complex, washed, and assayed for radioactivity (19) . Incorporation of ["C]formate into the purines excreted by the cells into the growth medium was measured essentially as described by Green and Martin (20) . 0.5-1.5 X 10' cells growing in nonconfluent monolayer in 75-cm2 Falcon Plastics culture flasks were incubated for 6 h with 10 ml of fresh growth medium containing 10 ACi ["C]formate. At the end of incubation, the purines in the total volume of the growth medium were Feedback-Resistant Phosphoribosylpyrophosphate Synthetase 1095 precipitated and counted (19) . The results of both methods are corrected for incomplete recovery of purines, utilizing tritiated adenine as internal standard, and are related to total cell proein (21) . In the fibroblasts of all subjects studied, labeling of purine nucleotides and of purines excreted into the medium was linear with time for at least 6 and 8 h, respectively, and for a fixed period of incubation was also proportional to the number of cells incubated.
RESULTS
Properties of PRPP synthetase. The mean activity of PRPP synthetase in dialyzed lysates of cultured fibroblasts from the propositus (0. G.) was significantly higher than that from the control subjects, the increase being more marked at the lower Pi concentration applied (2.95-fold, P < 0.025) than at the higher Pi concentration (1.27-fold, P < 0.05). The specific activity of PRPP synthetase in fibroblast lysates from the mother (D. G.) was significantly increased (P <0.05) only at low Pi concentration (Table II) . Furthermore, the enzyme in the dialyzed lysates of fibroblasts from the propositus (0. G.) and from his mother (D. G.) exhibited decreased sensitivity to feedback-inhibition by ADP and GDP, the residual activity of the mutant enzyme in the presence of the inhibitor being approximately two to fourfold that of the normal enzyme, the ratio depending on the lysate protein concentration employed for study (Table III) .
PRPP content and availability. The mean PRPP concentration in the cultured fibroblasts of the propositus (0. G.) was 3.7-fold the mean PRPP concentration of normal cells, a value above the 99.5% confidence limit (> normal mean + 3 SD) (Table IV) The rate of incorporation of labeled adenine and of labeled hypoxanthine into the total nucleotide pool of 4 Five subjects for PRPP content, six for adenine incorporation, and three for hypoxanthine incorporation.
formate was accelerated in the propositus (0. G.) by 15-fold, in his mother (D. G.) by 9-fold and in the Lesch-Nyhan patient (T. N.) by 10-fold the normal mean. All these values are above the normal mean + 3 SD limit. The fibroblasts of the patient's father (I. G.), healthy brother (A. G.), and three sons exhibited normal rates of purine synthesis de novo (Table V) .
DISCUSSION
In this study we demonstrate the presence of mutant feedback-resistant PRPP synthetase in the fibroblasts of the propositus (0. G.) and of his mother (D. G.), members of a family affected with excessive purine production associated with gout and uric acid lithiasis. In the propositus and his similarly affected brother (H. G.) this mutation was previously detected in the erythrocytes.
Similarly to the erythrocyte mutant enzyme (10), the PRPP synthetase in the propositus' fibroblasts exhibited resistance to inhibition by the purine nucleotides ADP and GDP. A similar resistance to inhibition was exhibited by the PRPP synthetase in lysates of the mother's (D. G.) fibroblasts. The finding of increased specific activity of PRPP synthetase in the dialyzed fibroblast lysate of the propositus, especially at high Pi concentration, appears inconsistent with the normal or even lower specific activity of the enzyme previously found The feedback-resistance of the PRPP synthetase in the fibroblast of the propositus and his mother manifest in superactivity of the enzyme, resulted in increased cellular content and metabolic availability of PRPP. The metabolic availability of PRPP was assessed by measuring the incorporation of labeled adenine and of labeled hypoxanthine into the intact fibroblast total nucleotide pool. The rate of these incorporations is dependent on the activity of the respective phosphoribosyltransferase, as well as on the size of the cold intracellular pools of adenine and hypoxanthine. The latter parameters were not determined, but the specific activities of adenine phosphoribosyltransferase (APRT) and HGPRT were found normal in the lysate of the propositus' fibroblasts; being 238 and 106 nmol/mg protein per h, respectively, as compared to the normal range as determined in our laboratory, 200-300 nmol/mg protein per h for APRT and 100-180 nmol/mg protein per h for HGPRT (22) . In view of the normal activity of the phosphoribosyltransferases and of the higher PRPP content demonstrated in the cells of the propositus and his mother, it seems most likely that the increased rate of adenine and of hypoxanthine incorporation into their fibroblast nucleotides, by 66 and by 149%, respectively, reflects increased metabolic availability of PRPP. Increased PRPP availability was also found in the fibroblasts of the Lesch-Nyhan patient (T. N.), but the underlying mechanism in these mutations is different, being caused in the PRPP synthetase mutation by increased PRPP synthesis and, in HGPRT deficiency by decreased PRPP utilization. The HGPRT deficiency in the fibroblasts of the Lesch-Nyhan patient (T. N.) was manifest also in the negligible incorporation of hypoxanthine into fibroblast nucleotides, similarly to what has been found by other investigators (23) .
In this study we demonstrated accelerated de novo purine nucleotide synthesis in the fibroblasts of the propositus (O. G.) and his mother (D. G). Increased PRPP availability is the most likely explanation for the excessive rate of purine production in these two subjects. A similar mechanism is held to be operating in cells of patients with Lesch-Nyhan syndrome (5).
A marked difference was noted in the ratio between the rate of incorporation of ["4C]formate into the cellular nucleotides and that into the purines excreted into the medium by normal cells, cells with mutant PRPP synthetase, and HGPRT-deaicient cells. This difference may be attributed to the different kinetics of purine nucleotide metabolism characterizing these various cells.
The pattern of transmission for this disorder has yet not been fully clarified. In the presently reported family, the father (I. G.), one brother (A. G.), and all four sons of the propositus were found normal by the clinical and biochemical criteria studied. On the other hand, the propositus' other brother (H. G.) as well as his mother (D. G.) were found to be affected. Whereas the biochemical and clinical manifestations of the defect in this brother (H. G.) were similar to that in propositus (O. G.), these manifestations in the mother (D. G.) were attenuated. She exhibited hyperuricosuria, but she was normouricemic and never suffered from gouty arthritis or kidney stones. No abnormality could be detected in her erythrocytes (8) , but her fibroblasts exhibited increased PRPP content and availability and accelerated synthesis de novo of purine nucleotides, the increase above normal in these parameters ranging from 56-72% the increase exhibited by the fibroblasts from her affected son (O. G.). On the basis of the available data, the mother (D. G.) could be heterozygous for either X-linked recessive or autosomal dominant traits. An autosomal dominant trait has indeed been suggested for the family with mutant PRPP synthetase reported by Becker et al. (11) .
If the mother is an heterozygote for X-linked recessive trait, then her fibroblast cultures should contain two cell populations, the normal and the mutant. On the other hand, if the mother is heterozygous for autosomal dominant trait, her fibroblast cultures should contain only the mutant cell population. Studies carried in our laboratory, aiming at the demonstration of two cell populations in the mother's cell cultures, by selecting 1098 E. Zoref, A. de Vries, and 0. Sperling for the mutant cell, yielded negative results. The method utilized was essentially that described by Green and Martin (20) . Addition to the fibroblast culture media of methylmercaptopurine ribonucleoside (0.2 mM), uridine (0.5 mM), and hypoxanthine (0.2 mM), caused the death of normal cells but allowed the survival of cells from the propositus (O. G.), which possess increased purine salvage capability. Under these conditions, the fibroblast cultures of the propositus' mother (D. G.) behaved similarly. This finding indicates the presence of a homogenous mutant cell population in the mother's fibroblast and thus supports the suggestion that the mutant PRPP synthetase in this family is transmitted as an autosomal dominant trait.
